MORGAN STANLEY PLC/CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/19.12.25 Share Price

Warrant

DE000MG0Z9W2

Market Closed - Börse Stuttgart 16:54:37 24/05/2024 BST
2.8 EUR -1.75% Intraday chart for MORGAN STANLEY PLC/CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/19.12.25
Current month+67.66%
1 month+141.38%
Date Price Change
24/05/24 2.8 -1.75%
23/05/24 2.85 -2.73%
22/05/24 2.93 +6.93%
21/05/24 2.74 -0.72%
20/05/24 2.76 +4.15%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 04:54 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer Morgan Stanley
WKN MG0Z9W
ISINDE000MG0Z9W2
Date issued 28/03/2024
Strike 20 $
Maturity 19/12/2025 (574 Days)
Parity 1 : 1
Emission price 1.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.11
Lowest since issue 0.88
Spread 0.08
Spread %2.84%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.6 USD
Average target price
17.54 USD
Spread / Average Target
+5.64%
Consensus